ANI Pharmaceuticals Inc’s recent filing unveils that its SR. VP, GENERAL COUNSEL & SEC. Cook Meredith unloaded Company’s shares for reported $14905.0 on Aug 13 ’24. In the deal valued at $59.62 per share,250 shares were sold. As a result of this transaction, Cook Meredith now holds 56,988 shares worth roughly $3.49 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Shanmugam Muthusamy sold 2,743 shares, generating $170,066 in total proceeds. Upon selling the shares at $62.00, the HEAD OF R&D, COO-NOVITIUM OPS now owns 632,620 shares.
Before that, Shanmugam Muthusamy sold 22,000 shares. ANI Pharmaceuticals Inc shares valued at $1,413,940 were divested by the HEAD OF R&D, COO-NOVITIUM OPS at a price of $64.27 per share. As a result of the transaction, Shanmugam Muthusamy now holds 649,620 shares, worth roughly $39.75 million.
CapitalOne initiated its ANI Pharmaceuticals Inc [ANIP] rating to an Overweight in a research note published on March 15, 2024; the price target was $80. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in late August has reiterated a ‘”a Buy”‘ rating for it. Guggenheim began covering ANIP with “Buy” recommendation on March 01, 2023. H.C. Wainwright started covering the stock on September 07, 2022. It rated ANIP as “a Buy”.
Price Performance Review of ANIP
On Tuesday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock fall -0.07% to $61.19. Over the last five days, the stock has gained 3.80%. ANI Pharmaceuticals Inc shares have risen nearly 10.97% since the year began. Nevertheless, the stocks have risen 2.51% over the past one year. While a 52-week high of $70.81 was reached on 03/25/24, a 52-week low of $48.20 was recorded on 08/07/24. SMA at 50 days reached $62.10, while 200 days put it at $60.60.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 60.23, which if violated will result in even more drops to 59.26. On the upside, there is a resistance level at 61.82. A further resistance level may holdings at 62.44. The Relative Strength Index (RSI) on the 14-day chart is 50.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.81, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 35.75%. Stochastics%K at 59.53% indicates the stock is a holding.
How much short interest is there in ANI Pharmaceuticals Inc?
A steep rise in short interest was recorded in ANI Pharmaceuticals Inc stocks on 2024-07-31, dropping by 59556.0 shares to a total of 0.31 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 0.37 million shares. There was a decline of -19.25%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 02, 2021 when Truist began covering the stock and recommended ‘”a Buy”‘ rating along with a $70 price target.
